Schedule 13G ownership disclosure
KalVista Pharmaceuticals Inc
Security class unavailable · CUSIP: 483497103
Event date: 2023-01-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-23-002129
- Form type
- SC 13G
- Filer
- KalVista Pharmaceuticals, Inc.
- CIK
- CIK 1348911
- Filed
- Mar 10, 2023
- Reporting period
- Jan 25, 2023
- Description
- Schedule 13G beneficial ownership